Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Building a Clinically Relevant Risk Model: Predicting Risk of a Potentially Preventable Acute Care Visit for Patients Starting Antineoplastic Treatment.
Daly B, Gorenshteyn D, Nicholas KJ, Zervoudakis A, Sokolowski S, Perry CE, Gazit L, Baldwin Medsker A, Salvaggio R, Adams L, Xiao H, Chiu YO, Katzen LL, Rozenshteyn M, Reidy-Lagunes DL, Simon BA, Perchick W, Wagner I. Daly B, et al. Among authors: gorenshteyn d. JCO Clin Cancer Inform. 2020 Mar;4:275-289. doi: 10.1200/CCI.19.00104. JCO Clin Cancer Inform. 2020. PMID: 32213093 Free PMC article.
Analysis of a Remote Monitoring Program for Symptoms Among Adults With Cancer Receiving Antineoplastic Therapy.
Daly B, Nicholas K, Flynn J, Silva N, Panageas K, Mao JJ, Gazit L, Gorenshteyn D, Sokolowski S, Newman T, Perry C, Wagner I, Zervoudakis A, Salvaggio R, Holland J, Chiu YO, Kuperman GJ, Simon BA, Reidy-Lagunes DL, Perchick W. Daly B, et al. Among authors: gorenshteyn d. JAMA Netw Open. 2022 Mar 1;5(3):e221078. doi: 10.1001/jamanetworkopen.2022.1078. JAMA Netw Open. 2022. PMID: 35244701 Free PMC article.
Misery Loves Company: Presenting Symptom Clusters to Urgent Care by Patients Receiving Antineoplastic Therapy.
Daly B, Nicholas K, Gorenshteyn D, Sokolowski S, Gazit L, Adams L, Matays J, Katzen LL, Chiu YO, Xiao H, Salvaggio R, Baldwin-Medsker A, Chow K, Nelson J, Ross M, Ng KK, Zervoudakis A, Perchick W, Reidy DL, Simon BA, Wagner I. Daly B, et al. Among authors: gorenshteyn d. J Oncol Pract. 2018 Aug;14(8):e484-e495. doi: 10.1200/JOP.18.00199. Epub 2018 Jul 17. J Oncol Pract. 2018. PMID: 30016125 Free PMC article.
Modeling molecular development of breast cancer in canine mammary tumors.
Graim K, Gorenshteyn D, Robinson DG, Carriero NJ, Cahill JA, Chakrabarti R, Goldschmidt MH, Durham AC, Funk J, Storey JD, Kristensen VN, Theesfeld CL, Sorenmo KU, Troyanskaya OG. Graim K, et al. Among authors: gorenshteyn d. Genome Res. 2021 Feb;31(2):337-347. doi: 10.1101/gr.256388.119. Epub 2020 Dec 23. Genome Res. 2021. PMID: 33361113 Free PMC article.
Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases.
Gorenshteyn D, Zaslavsky E, Fribourg M, Park CY, Wong AK, Tadych A, Hartmann BM, Albrecht RA, García-Sastre A, Kleinstein SH, Troyanskaya OG, Sealfon SC. Gorenshteyn D, et al. Immunity. 2015 Sep 15;43(3):605-14. doi: 10.1016/j.immuni.2015.08.014. Epub 2015 Sep 8. Immunity. 2015. PMID: 26362267 Free PMC article.
Tissue-specific functional networks for prioritizing phenotype and disease genes.
Guan Y, Gorenshteyn D, Burmeister M, Wong AK, Schimenti JC, Handel MA, Bult CJ, Hibbs MA, Troyanskaya OG. Guan Y, et al. Among authors: gorenshteyn d. PLoS Comput Biol. 2012;8(9):e1002694. doi: 10.1371/journal.pcbi.1002694. Epub 2012 Sep 27. PLoS Comput Biol. 2012. PMID: 23028291 Free PMC article.